Barclays raised the firm’s price target on Keurig Dr Pepper to $38 from $36 and keeps an Overweight rating on the shares. The company reiterated its 2024 guidance for mid-single-digit organic sales growth and high-single-digit earnings growth, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper price target raised to $35 from $32 at TD Cowen
- Keurig Dr Pepper price target raised to $39 from $37 at Wells Fargo
- Early notable gainers among liquid option names on April 25th
- Keurig Dr Pepper Announces Leadership Transition and New CEO
- Keurig Dr Pepper Reports Q1 2024 Results and Reaffirms Fiscal 2024 Guidance